-
First trimester urinary placental growth factor and development of pre-eclampsia.
Savvidou M, Akolekar R, Zaragoza E, Poon L, Nicolaides K.
BJOG 2009;116:643-7. -
First-trimester prediction of hypertensive disorders in pregnancy.
Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH.
Hypertension 2009;53:812-8. -
Hypertensive disorders in pregnancy: screening by uterine artery Doppler imaging and blood pressure at 11-13 weeks.
Poon LC, Karagiannis G, Leal A, Romero XC, Nicolaides KH.
Ultrasound Obstet Gynecol 2009;34:497-502. -
Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11-13 weeks.
Poon LC, Staboulidou I, Maiz N, Plasencia W, Nicolaides KH.
Ultrasound Obstet Gynecol 2009;34:142-8. -
First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia.
Poon LC, Maiz N, Valencia C, Plasencia W, Nicolaides KH.
Ultrasound Obstet Gynecol 2009;33:23-33. -
First-trimester maternal serum tumor necrosis factor receptor-1 and pre-eclampsia.
Leal AM, Poon LC, Frisova V, Veduta A, Nicolaides KH.
Ultrasound Obstet Gynecol 2009;33:135-41. -
Maternal arterial stiffness in pregnancies affected by pre-eclampsia.
Kaihura C, Savvidou MD, Anderson JM, McEniery CM, Nicolaides KH.
Am J Physiol Heart Circ Physiol 2009;297:759-64. -
Contribution of the myocardial performance index and aortic isthmus blood flow index to predicting mortality in preterm growth-restricted fetuses.
Hernandez-Andrade E, Crispi F, Benavides-Serralde JA, Plasencia W, Diesel HF, Eixarch E, Acosta-Rojas R, Figueras F, Nicolaides K, Gratacós E.
Ultrasound Obstet Gynecol 2009;34:430-6. -
Three-dimensional sonographic calculation of the volume of intracranial structures in growth-restricted and appropriate-for-gestational age fetuses.
Benavides-Serralde A, Hernández-Andrade E, Fernández-Delgado J, Plasencia W, Scheier M, Crispi F, Figueras F, Nicolaides KH, Gratacós E.
Ultrasound Obstet Gynecol 2009;33:530-7. -
Maternal plasma pentraxin 3 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy.
Akolekar R, Casagrandi D, Livanos P, Tetteh A, Nicolaides KH.
Prenat Diagn 2009;29:934-8. -
Maternal serum angiopoietin-2 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy.
Akolekar R, Casagrandi D, Skyfta E, Ahmed AA, Nicolaides KH.
Prenat Diagn 2009;29:847-51. -
Maternal plasma inhibin A at 11-13 weeks of gestation in hypertensive disorders of pregnancy.
Akolekar R, Minekawa R, Veduta A, Romero XC, Nicolaides KH.
Prenat Diagn 2009;29:753-60. -
Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia.
Akolekar R, Syngelaki A, Beta J, Kocylowski R, Nicolaides KH.
Prenat Diagn 2009;29:1103-8. -
Maternal serum activin at 11-13 weeks of gestation in hypertensive disorders of pregnancy.
Akolekar R, Etchegaray A, Zhou Y, Maiz N, Nicolaides KH.
Fetal Diagn Ther 2009;25:320-7. -
Angiotensin II type 1 and 2 receptors gene polymorphisms in pre-eclampsia and normal pregnancy in three different populations.
Akbar SA, Khawaja NP, Brown PR, Tayyeb R, Bamfo J, Nicolaides KH.
Acta Obstet Gynecol Scand 2009;88:606-11. -
Progression of Doppler abnormalities in intrauterine growth restriction.
Turan OM, Turan S, Gungor S, Berg C, Moyano D, Gembruch U, Nicolaides KH, Harman CR, Baschat AA.
Ultrasound Obstet Gynecol 2008;32:160-7. -
Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia.
Spencer K, Cowans NJ, Nicolaides KH.
Ultrasound Obstet Gynecol 2008;32:622-6. -
Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia.
Spencer K, Cowans NJ, Nicolaides KH.
Prenat Diagn 2008;28:7-10. -
Circulating levels of adiponectin and leptin at 23-25 weeks of pregnancy in women with impaired placentation and in those with established fetal growth restriction.
Savvidou MD, Sotiriadis A, Kaihura C, Nicolaides KH, Sattar N.
Clin Sci (Lond) 2008;115:219-24. -
Mean arterial pressure at 11+0 to 13+6 weeks in the prediction of preeclampsia.
Poon LC, Kametas NA, Pandeva I, Valencia C, Nicolaides KH.
Hypertension 2008;51:1027-33.